Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil: A geographical comparison from a single arm, open-label study

Journal of Sexual Medicine

Volumn 6, Issue 10, 2009, Pages 2836-2850

  Rubio Aurioles, Eusebio ^a   Glina, Sidney ^b   Abdo, Carmita H N ^c   Hernandez Serrano, Ruben ^d   Rampazzo, Claudia ^a   Sotomayor, Mariano ^e   West, Teena M ^f   Gallagher, Gabrielle L ^f   Lenero, Enrique ^g  

^a AMSSAC   (Mexico)

^b Ipiranga Hospital   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^e INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^f ELI LILLY AUSTRALIA PTY LTD   (Australia)

^g Eli Lilly Mexico   (Mexico)

Author keywords

Erectile dysfunction; Geography; PDE5 inhibitors; Sexual behavior; Sildenafil citrate; Tadalafil

Indexed keywords

SILDENAFIL; TADALAFIL; CARBOLINE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; SULFONE;

ADULT; ANGINA PECTORIS; ARTICLE; ASIA; AUSTRALIA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; DYSPEPSIA; DYSPNEA; ERECTILE DYSFUNCTION; EUROPE; EYELID EDEMA; GEOGRAPHIC DISTRIBUTION; HEART INFARCTION; HOT FLUSH; HUMAN; HYPERTENSION; HYPESTHESIA; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; MULTICENTER STUDY; MYALGIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SOUTH AND CENTRAL AMERICA; TREATMENT DURATION; TREATMENT RESPONSE; ANALYSIS OF VARIANCE; COITUS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; GEOGRAPHY; HEALTH STATUS INDICATOR; IMPOTENCE, VASCULOGENIC; MIDDLE AGED; NEW ZEALAND; PATIENT SATISFACTION; TIME FACTOR;

ANALYSIS OF VARIANCE; ASIA; AUSTRALIA; CARBOLINES; COITUS; CONFIDENCE INTERVALS; EUROPE; GEOGRAPHY; HEALTH STATUS INDICATORS; HUMANS; IMPOTENCE, VASCULOGENIC; LATIN AMERICA; MALE; MIDDLE AGED; MIDDLE EAST; NEW ZEALAND; PATIENT SATISFACTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SILDENAFIL CITRATE; SULFONES; TADALAFIL; TIME FACTORS;

EID: 70649113102     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01413.x     Document Type: Article

References (27)

1. Porst H, Padma-Nathan H, Giuliano F, Anglin G, Varanese L, Rosen R. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: A randomized controlled trial. Urology 2003, 62:121-5.
2. Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM, Hague JA, Ahuja S. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. J Androl 2005, 26:310-8.
3. Gingell C, Sultana SR, Wulff MB, Gepi-Attee S. Duration of action of sildenafil citrate in men with erectile dysfunction. J Sex Med 2004, 1:179-84.
4. Shabsigh R, Burnett AL, Eardley I, Sharlip ID, Ellsworth PI, Garcia CS, Natanegara F, Ahuja S. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. BJU Int 2005, 96:857-63.
5. Glina S, Sotomayor M, Gatchalian E, Yaman O, Dyachkova Y, Markey C, Kopernicky V. Timing of dose relative to sexual intercourse attempt in previous sildenafil citrate users treated with tadalafil. J Sex Med 2006, 3:309-19.
6. Gregersen E. Sexual practices: The story of human sexuality 1983, 320. New York, Franklin Watts
7. Swindle RW, Cameron AE, Lockhart DC, Rosen RC. The psychological and interpersonal relationship scales: Assessing psychological and relationship outcomes associated with erectile dysfunction and its treatment. Arch Sex Behav 2004, 33:19-30.
8. Seftel AD, Wilson SK, Knapp PM, Shin J, Wang WC, Ahuja S. The efficacy and safety of tadalafil in United States and Puerto Rican men with erectile dysfunction. J Urol 2004, 172:652-7.
9. Shabsigh R, Althof S, Broderick G, Natanegara F, Garcia CS, Wong D, Ahuja S. When do couples have sex? Analyses by age and marital status of data from a tadalafil clinical trial. Proceedings of the Sexual Medicine Association of North America Fall Meeting; 2006 Nov 02-5; Las Vegas, NV
10. Eardley I, Dean J, Barnes T, Kirby M, Glasser D, Solanki J. The sexual habits of British men and women over 40 years old. BJU Int 2004, 93:563-7.
11. Colson MH, Lemaire A, Pinton P, Hamidi K, Klein P. Sexual behaviors and mental perception, satisfaction and expectations of sex life in men and women in France. J Sex Med 2006, 3:121-31.
12. Ahn TY, Lee SW, Kim SW, Yang DY, Park NC, Min KS, Park K, Paick JS, Dyachkova Y, Dwight T, Lee MS. Treatment preferences in men with erectile dysfunction: An open label study in Korean men switching from sildenafil citrate to tadalafil. Asian J Androl 2007, 9:760-70.
13. Wang TF, Lu CH, Chen IJ, Yu S. Sexual knowledge, attitudes and activity of older people in Taipei, Taiwan. J Clin Nurs 2008, 17:443-50.
14. Govier F, Potempa AJ, Kaufman J, Denne J, Kovalenko P, Ahuja S. A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sildenafil citrate 50 mg during initiation of treatment for erectile dysfunction. Clin Ther 2003, 25:2709-23.
15. Stroberg P, Murphy A, Costigan T. Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: Results of a European multicenter, open-label study of patient preference. Clin Ther 2003, 25:2724-37.
16. von Keitz A, Rajfer J, Segal S, Murphy A, Denne J, Costigan T, Lockhart D, Beasley CM, Emmick JT. A multicenter, randomized, double-blind, crossover study to evaluate patient preference between tadalafil and sildenafil. Eur Urol 2004, 45:499-507.
17. Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy: Post hoc analysis of data from a multicentre, randomized, open-label, crossover study. BJU Int 2007, 100:122-9.
18. McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, Sutherland PD, Palmer NR, Lowy MP, Jesudason DR, Fredlund P. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: A randomised, double-blind, parallel-group, placebo-controlled study in Australian men. Int J Clin Pract 2005, 59:143-9.
19. McMahon CG, Samali R, Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 2000, 164:1192-6.
20. Tan HM, Moh CL, Mendoza JB, Gana T, Albano GJ, de la Cruz R, Chye PL, Sam CC. Asian sildenafil efficacy and safety study (ASSESS-1): A double-blind, placebo-controlled, flexible-dose study of oral sildenafil in Malaysian, Singaporean, and Filipino men with erectile dysfunction. The Assess-1 Study Group. Urology 2000, 56:635-40.
21. Yip WC, Chiang HS, Mendoza JB, Tan HM, Li MK, Wang WC, Kopernicky V. Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: A randomized double-blind, parallel, placebo-controlled clinical study. Asian J Androl 2006, 8:685-92.
22. Eardley I, Mirone V, Montorsi F, Ralph D, Kell P, Warner MR, Zhao Y, Beardsworth A. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy. BJU Int 2005, 96:1323-32.
23. Skoumal R, Chen J, Kula K, Breza J, Calomfirescu N, Basson BR, Kopernicky V. Efficacy and treatment satisfaction with on-demand tadalafil (cialis) in men with erectile dysfunction. Eur Urol 2004, 46:362-9.
24. Becher E, Tejada NA, Gomez R, Decia R. Sildenafil citrate (Viagra) in the treatment of men with erectile dysfunction in southern Latin America: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, flexible-dose escalation study. Int J Impot Res 2002, 14(2):S33-41. suppl
25. Glina S, Bertero E, Claro J, Damiao R, Faria G, Fregonesi A, Jaspersen J, Mendoza A, Mattos D, Rocha LC, Sotomayor M, Teloken C, Ureta S, Zonana E, Ugarte F. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men. Int J Impot Res 2002, 14(2):S27-32. suppl
26. Rubio-Aurioles E, Casabe A, Torres LO, Quinzanos L, Glina S, Filimon I, Kopernicky V, Lenero E. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: Results of integrated analyses. J Sex Med 2008, 5:1965-76.
27. Nicolosi A, Glasser DB, Kim SC, Marumo K, Laumann EO. Sexual behaviour and dysfunction and help-seeking patterns in adults aged 40-80 years in the urban population of Asian countries. BJU Int 2005, 95:609-14.